Jonah Meer - Qrons CEO, CoFounder

QRON Stock  USD 0.18  0.01  5.26%   

Insider

Jonah Meer is CEO, CoFounder of Qrons Inc
Age 68
Phone212 945 2080
Webhttps://qrons.com

Qrons Management Efficiency

The company has return on total asset (ROA) of (14.9238) % which means that it has lost $14.9238 on every $100 spent on assets. This is way below average. Qrons' management efficiency ratios could be used to measure how well Qrons manages its routine affairs as well as how well it operates its assets and liabilities.
Qrons Inc currently holds 370 K in liabilities with Debt to Equity (D/E) ratio of 23.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Qrons Inc has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qrons until it has trouble settling it off, either with new capital or with free cash flow. So, Qrons' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qrons Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qrons to invest in growth at high rates of return. When we think about Qrons' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

INSIDER Age

Stephen JDGeron
74
Prof EhrlichABIVAX Socit Anonyme
N/A
Regina JehleABIVAX Socit Anonyme
N/A
Anne PascardABIVAX Socit Anonyme
N/A
Raquel LizarragaABIVAX Socit Anonyme
N/A
Alain ChevallierABIVAX Socit Anonyme
70
David InnesNorthwest Biotherapeutics
N/A
Pierre MBAABIVAX Socit Anonyme
N/A
Paul GinesteABIVAX Socit Anonyme
N/A
, MBANorthwest Biotherapeutics
64
Philippe MDABIVAX Socit Anonyme
65
Linda JDNorthwest Biotherapeutics
67
Jean DavisNorthwest Biotherapeutics
51
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York. Qrons operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people. Qrons Inc [QRON] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Qrons Inc Leadership Team

Elected by the shareholders, the Qrons' board of directors comprises two types of representatives: Qrons inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qrons. The board's role is to monitor Qrons' management team and ensure that shareholders' interests are well served. Qrons' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qrons' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonah Meer, CEO, CoFounder
Ido Merfeld, Pres CoFounder

Qrons Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Qrons a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Qrons

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qrons position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qrons will appreciate offsetting losses from the drop in the long position's value.

Moving together with Qrons OTC Stock

  0.69NVO Novo Nordisk ASPairCorr
  0.72NONOF Novo Nordisk ASPairCorr

Moving against Qrons OTC Stock

  0.71AVTE Aerovate TherapeuticsPairCorr
  0.68BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.63HNRC Houston Natural ResourcesPairCorr
  0.45GOOG Alphabet Class C Aggressive PushPairCorr
  0.34SLF Sun Life FinancialPairCorr
The ability to find closely correlated positions to Qrons could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qrons when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qrons - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qrons Inc to buy it.
The correlation of Qrons is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qrons moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qrons Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qrons can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Qrons OTC Stock

Qrons financial ratios help investors to determine whether Qrons OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qrons with respect to the benefits of owning Qrons security.